HCO ANTIBODY, INC.
Menlo Park, CA · Biotech · Private
Bispecific antibody therapeutic targeting folate receptor on high-grade serous carcinoma with dual-epitope binding and T cell activation
teneobio.com →- Grants
- $887K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of novel heavy chain antibody-based therapeutics for polyomavirus infections | $291,478 | |
| Federal grant | Department of Health and Human Services · Phase I · Bispecific Antibodies Directed to CD3and HBsAg to Treat Chronic Hepatitis B Virus | $296,876 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Fr? x Fr? x CD3 trivalent, biparatopic T-cell engaging antibody to treat high grade serous carcinoma | $298,345 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1840 | Entelo, Inc. | — | $4.9M |
| 1841 | KDAc Therapeutics, Inc. | — | — |
| 1842 | SCRIPT BIOSCIENCES INC | — | — |
| 1843 | HCO ANTIBODY, INC. | — | — |
| 1844 | MARIPOSA HOLDINGS GROUP, INC. | — | $280K |
| 1845 | Javelin Oncology, Inc. | — | $1.5M |
| 1846 | ABILITY Network Inc. | — | $20M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Recombinant Production Of Mixtures Of Single Chan Antibodiesapplication
- Bispecific Three-chain Antibody-like Moleculesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.